The Effect of Cinnamon on Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome; a Pilot Study

NCT03946163 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-04-02

No results posted yet for this study

Summary

Chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) is one of the common urologic problems, nevertheless; its etiology and pathophysiology are poorly understood, with no solid guidelines for effective treatment. The beneficial health attributes of cinnamon and its derivative and components were reported by several researchers, this study is designed to illuminate the possible benefits of cinnamon on patients with Chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS)

Conditions

  • Chronic Prostatitis
  • Chronic Pelvic Pain Syndrome

Interventions

DIETARY_SUPPLEMENT

cinnamon capsules

each patient will receive sixty capsules, each capsule contained 1gm of cinnamon bark powder and instructed to use it twice daily for one month

DRUG

Placebo oral capsule

each patient will receive sixty capsules, each capsule contained placebo and instructed to use it twice daily for one month

Sponsors & Collaborators

  • Al-Kindy College of Medicine

    lead OTHER

Principal Investigators

  • Tawfik J Al-Marzooq, F.I.C.M.S. · University of Baghdad- Alkindy collage of medicine

  • Qays A Al-Timimy, F.I.C.M.S. · University of Baghdad- Alkindy collage of medicine

  • Harth M Kamber, F.I.C.M.S. · University of Baghdad- Alkindy collage of medicine

  • Malath A Hussein, F.I.C.M.S. · University of Baghdad- Alkindy collage of medicine

  • Ahmed A Marzouq, F.I.C.M.S. · University of Baghdad- Alkindy collage of medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03946163 on ClinicalTrials.gov